HOXC11 drives lung adenocarcinoma progression through transcriptional regulation of SPHK1

[1]  R. Sorrentino,et al.  S1P-Induced TNF-α and IL-6 Release from PBMCs Exacerbates Lung Cancer-Associated Inflammation , 2022, Cells.

[2]  A. Tan,et al.  Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations. , 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  Linna Liu,et al.  HOXC11 Expression Is Associated with the Progression of Colon Adenocarcinoma and Is a Prognostic Biomarker. , 2021, DNA and cell biology.

[4]  M. Qin,et al.  SphK1‐driven autophagy potentiates focal adhesion paxillin‐mediated metastasis in colorectal cancer , 2021, Cancer medicine.

[5]  Yinling Hu,et al.  Attribution of NF-κB Activity to CHUK/IKKα-Involved Carcinogenesis , 2021, Cancers.

[6]  Y. Tao,et al.  The Significance of HOXC11 and LSH in Survival Prediction in Gastric Adenocarcinoma , 2021, OncoTargets and therapy.

[7]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[8]  K. Takabe,et al.  Sphingosine 1-phosphate (S1P) produced by sphingosine kinase 1 (SphK1) and exported via ABCC1 is related to hepatocellular carcinoma (HCC) progression. , 2021, American journal of cancer research.

[9]  Xiaoping Yang,et al.  SphK1 promotes development of non‑small cell lung cancer through activation of STAT3. , 2020, International journal of molecular medicine.

[10]  S. Sukumar,et al.  HOX genes and the NF-κB pathway: A convergence of developmental biology, inflammation and cancer biology. , 2020, Biochimica et biophysica acta. Reviews on cancer.

[11]  Yue Yang,et al.  The Tumorigenic Effect of Sphingosine Kinase 1 and Its Potential Therapeutic Target , 2020, Cancer control : journal of the Moffitt Cancer Center.

[12]  A. Ardizzoni,et al.  Beyond EGFR, ALK and ROS1: Current evidence and future perspectives on newly targetable oncogenic drivers in lung adenocarcinoma. , 2020, Critical reviews in oncology/hematology.

[13]  Petra Grbčić,et al.  Sphingosine 1-Phosphate Signaling and Metabolism in Chemoprevention and Chemoresistance in Colon Cancer , 2020, Molecules.

[14]  P. Brousset,et al.  Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1 , 2020, Nature Communications.

[15]  W. Cao,et al.  HOXC11 functions as a novel oncogene in human colon adenocarcinoma and kidney renal clear cell carcinoma. , 2020, Life sciences.

[16]  L. Huang,et al.  Prognostic roles of the expression of sphingosine-1-phosphate metabolism enzymes in non-small cell lung cancer. , 2019, Translational lung cancer research.

[17]  Haiyan Zhou,et al.  MicroRNA-1197 downregulation inhibits proliferation and migration in human non- small cell lung cancer cells by upregulating HOXC11. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[18]  Xiqiao Zhou,et al.  SphK1 functions downstream of IGF-1 to modulate IGF-1-induced EMT, migration and paclitaxel resistance of A549 cells: A preliminary in vitro study , 2019, Journal of Cancer.

[19]  Jun Yao,et al.  Sphingosine-kinase-1 signaling promotes metastasis of triple-negative breast cancer. , 2019, Cancer research.

[20]  Xiuping Chen,et al.  The sphingosine kinase‐1/sphingosine‐1‐phosphate axis in cancer: Potential target for anticancer therapy , 2019, Pharmacology & therapeutics.

[21]  Z. Miao,et al.  SPHK1‐induced autophagy in peritoneal mesothelial cell enhances gastric cancer peritoneal dissemination , 2019, Cancer medicine.

[22]  J. Paramio,et al.  IKKα Promotes the Progression and Metastasis of Non-Small Cell Lung Cancer Independently of its Subcellular Localization , 2019, Computational and structural biotechnology journal.

[23]  E. Lengyel,et al.  SPHK1 Is a Novel Target of Metformin in Ovarian Cancer , 2019, Molecular Cancer Research.

[24]  N. S. Yarla,et al.  Regulatory role of sphingosine kinase and sphingosine-1-phosphate receptor signaling in progenitor/stem cells , 2018, World journal of stem cells.

[25]  T. Goldmann,et al.  IκB Kinase α Is Required for Development and Progression of KRAS-Mutant Lung Adenocarcinoma. , 2018, Cancer research.

[26]  K. Inamura.  Clinicopathological Characteristics and Mutations Driving Development of Early Lung Adenocarcinoma: Tumor Initiation and Progression , 2018, International journal of molecular sciences.

[27]  K. Sakimura,et al.  Targeting the SphK1/S1P/S1PR1 Axis That Links Obesity, Chronic Inflammation, and Breast Cancer Metastasis. , 2018, Cancer research.

[28]  Roy S. Herbst,et al.  The biology and management of non-small cell lung cancer , 2018, Nature.

[29]  R. Nussinov,et al.  IKKα inactivation promotes Kras-initiated lung adenocarcinoma development through disrupting major redox regulatory pathways , 2018, Proceedings of the National Academy of Sciences.

[30]  B. Ogretmen,et al.  Sphingolipid metabolism in cancer signalling and therapy , 2017, Nature Reviews Cancer.

[31]  A. Huwiler,et al.  The sphingosine 1-phosphate receptor modulator fingolimod as a therapeutic agent: Recent findings and new perspectives. , 2017, Pharmacology & therapeutics.

[32]  D. Baltimore,et al.  30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology , 2017, Cell.

[33]  J. Hecht,et al.  Deletions of 5′ HOXC genes are associated with lower extremity malformations, including clubfoot and vertical talus , 2016, Journal of Medical Genetics.

[34]  A. Hill,et al.  Prosaposin activates the androgen receptor and potentiates resistance to endocrine treatment in breast cancer , 2015, Breast Cancer Research.

[35]  W. Weng,et al.  SphK1 inhibitor II (SKI-II) inhibits acute myelogenous leukemia cell growth in vitro and in vivo. , 2015, Biochemical and biophysical research communications.

[36]  A. Hill,et al.  Global gene repression by the steroid receptor coactivator SRC-1 promotes oncogenesis. , 2014, Cancer research.

[37]  A. Hoffmann,et al.  Chromatin-bound IκBα regulates a subset of polycomb target genes in differentiation and cancer. , 2013, Cancer cell.

[38]  W. Li,et al.  Inhibition of sphingosine kinase 1 suppresses proliferation of glioma cells under hypoxia by attenuating activity of extracellular signal‐regulated kinase , 2012, Cell proliferation.

[39]  Sarah Spiegel,et al.  Sphingosine-1-phosphate signaling and its role in disease. , 2012, Trends in cell biology.

[40]  Zhuan Zhou,et al.  An novel role of sphingosine kinase-1 (SPHK1) in the invasion and metastasis of esophageal carcinoma , 2011, Journal of Translational Medicine.

[41]  A. Hill,et al.  HOXC11–SRC-1 regulation of S100beta in cutaneous melanoma: new targets for the kinase inhibitor dasatinib , 2011, British Journal of Cancer.

[42]  E. Koyama,et al.  Hox11 genes establish synovial joint organization and phylogenetic characteristics in developing mouse zeugopod skeletal elements , 2010, Development.

[43]  Arnold D K Hill,et al.  Interaction of developmental transcription factor HOXC11 with steroid receptor coactivator SRC-1 mediates resistance to endocrine therapy in breast cancer [corrected]. , 2010, Cancer research.

[44]  L. Young,et al.  Interaction of Developmental Transcription Factor HOX11 with Steroid Receptor Coactivator SRC-1 Mediates Resistance to Endocrine Therapy in Breast Cancer , 2010 .

[45]  Libing Song,et al.  Sphingosine kinase-1 Enhances Resistance to Apoptosis through Activation of PI 3 K / Akt / NF-κ B Pathway in Human Non-small Cell Lung Cancer , 2010 .

[46]  S. Milstien,et al.  Targeting SphK1 as a new strategy against cancer. , 2008, Current drug targets.

[47]  Q. Wang,et al.  Major form of NUP98/HOXC11 fusion in adult AML with t(11;12)(p15;q13) translocation exhibits aberrant trans-regulatory activity , 2003, Leukemia.

[48]  Y. Hayashi,et al.  Novel NUP98-HOXC11 fusion gene resulted from a chromosomal break within exon 1 of HOXC11 in acute myeloid leukemia with t(11;12)(p15;q13). , 2002, Cancer research.

[49]  M. Capecchi,et al.  Hox11 paralogous genes are essential for metanephric kidney induction. , 2002, Genes & development.

[50]  M. Capecchi,et al.  The mouse Hoxc11 gene: genomic structure and expression pattern , 1998, Mechanisms of Development.